UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary Sjögren's syndrome: Longitudinal real‐world, observational data on health‐related quality of life

Journal of internal medicine, 2022-06, Vol.291 (6), p.849-855

2022

Volltextzugriff (PDF)

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Rheumatology (Oxford, England), 2015-12, Vol.54 (12), p.2230-2238

2015

Volltextzugriff (PDF)

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.977-985

2016

Volltextzugriff (PDF)

Extranodal marginal zone lymphoma as the presenting feature of paediatric Sjögren syndrome

Pediatric blood & cancer, 2023-10, Vol.70 (10), p.e30476-n/a

2023

Volltextzugriff (PDF)

Examining the biological pathways underlying clinical heterogeneity in Sjogren’s syndrome: proteomic and network analysis

Annals of the rheumatic diseases, 2024-01, Vol.83 (1), p.88-95

2024

Volltextzugriff (PDF)

Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome

Rheumatology international, 2020-04, Vol.40 (4), p.541-548

2020

Volltextzugriff (PDF)

Comorbidities in the UK Primary Sjögren's Syndrome Registry

Frontiers in immunology, 2022-04, Vol.13, p.864448

2022

Volltextzugriff (PDF)

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome

Rheumatic & musculoskeletal diseases open, 2019-10, Vol.5 (2), p.e001064

2019

Volltextzugriff (PDF)

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine

Rheumatology international, 2021-09, Vol.41 (9), p.1593-1600

2021

Volltextzugriff (PDF)

Impaired functional status in primary Sjögren's syndrome

Arthritis care & research (2010), 2012-11, Vol.64 (11), p.1760-1764

2012

Volltextzugriff (PDF)

Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma

Annals of the rheumatic diseases, 2016-04, Vol.75 (4), p.780-783

2016

Volltextzugriff (PDF)

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations

Expert review of clinical immunology, 2016-02, Vol.12 (2), p.137-156

2016

Volltextzugriff (PDF)

Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study

Digital health, 2023-01, Vol.9, p.20552076231181239-20552076231181239

2023

Volltextzugriff (PDF)

New developments in Sjogren’s syndrome

Rheumatology (Oxford, England), 2021-12, Vol.60 (Supplement_6), p.vi53-vi61

2021

Volltextzugriff (PDF)

Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities

Frontiers in neurology, 2023, Vol.14, p.1210974-1210974

2023

Volltextzugriff (PDF)

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial

The Lancet. Rheumatology, 2021-05, Vol.3 (5), p.e337-e346

2021

Volltextzugriff (PDF)

Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype

Frontiers in immunology, 2022-07, Vol.13, p.840751

2022

Volltextzugriff (PDF)

Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2019-11, Vol.18 (6), p.632-635

2019

Volltextzugriff (PDF)

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome

BMC medical genetics, 2017-03, Vol.18 (1), p.29, Article 29

2017

Volltextzugriff (PDF)

Activity interference in patients with Sjögren’s syndrome: a cross-sectional study of 149 patients in the UK

Rheumatology (Oxford, England), 2022-10, Vol.61 (10), p.4065-4075

2022

Volltextzugriff (PDF)

Fatigue assessment using ECG and actigraphy sensors

Proceedings of the 2020 ACM International Symposium on Wearable Computers, 2020, p.12-16

2020

Volltextzugriff (PDF)

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome

Annals of the rheumatic diseases, 2017-07, Vol.76 (7), p.1161-1168

2017

Volltextzugriff (PDF)

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Annals of the rheumatic diseases, 2016-02, Vol.75 (2), p.382-389

2016

Volltextzugriff (PDF)

Role of autonomic dysregulation in quality of life and functional impairment in implantable cardioverter defibrillator patients

Journal of psychosomatic research, 2023-08, Vol.171, p.111390-111390, Article 111390

2023

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Aktive Filter

ThemaFatigue

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

Englisch
(163)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Primary Sjögren's syndrome: Longitudinal real‐world, observational data on health‐related quality of life

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Extranodal marginal zone lymphoma as the presenting feature of paediatric Sjögren syndrome

Examining the biological pathways underlying clinical heterogeneity in Sjogren’s syndrome: proteomic and network analysis

Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome

Comorbidities in the UK Primary Sjögren's Syndrome Registry

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine

Impaired functional status in primary Sjögren's syndrome

Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations

Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study

New developments in Sjogren’s syndrome

Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial

Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype

Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic

Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome

Activity interference in patients with Sjögren’s syndrome: a cross-sectional study of 149 patients in the UK

Fatigue assessment using ECG and actigraphy sensors

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome

Reverse Engineering of Digital Measures: Inviting Patients to the Conversation

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Role of autonomic dysregulation in quality of life and functional impairment in implantable cardioverter defibrillator patients

Aktive Filter

Suchergebnisse filtern